Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 305.10
+11.50 (3.92%)
Aug 7, 2026, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.3 trillion as of August 7, 2026. Its market cap has decreased by -4.37% in one year.
Market Cap
1.30T
Enterprise Value
1.39T
Revenue
329.43B
Ranking
n/a
PE Ratio
11.21
Stock Price
305.10
ChartMarket Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.30T, an increase of 2,722.80%. That is a compound annual growth rate of 12.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 1.30T | -10.15% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genmab | 116.16B |
| Coloplast | 95.94B |
| Demant | 59.30B |
| ALK-Abelló | 48.79B |
| H. Lundbeck | 39.94B |
| Zealand Pharma | 22.89B |
| Ambu A/S | 19.33B |
| GN Store Nord | 14.48B |